Augmented antitumor effects of killer cells induced by tumor necrosis factor gene-transduced autologous tumor cells from gastrointestinal cancer patients

Human Gene Therapy

Volumn 7, Issue 15, 1996, Pages 1895-1905

  Sato, Yasushi ^a   Koshita, Yoshikazu ^a   Hirayama, Michiaki ^a   Matuyama, Tomohiko ^a   Wakimoto, Hiroaki ^b   Hamada, Hirofumi ^b   Niitsu, Yoshiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CANCER VACCINE; HLA ANTIBODY; HLA ANTIGEN CLASS 1; INTERCELLULAR ADHESION MOLECULE 1; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR; VIRUS VECTOR;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL MEDIATED CYTOTOXICITY; COLON CANCER; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXIC T LYMPHOCYTE; DAUDI CELL; DIGESTIVE SYSTEM CANCER; FEMALE; GENE INDUCTION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; KILLER CELL; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PROTEIN EXPRESSION; RETROVIRUS; STOMACH CANCER; TUMOR CELL;

UNIDENTIFIED RETROVIRUS;

EID: 0029913929     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.15-1895     Document Type: Article

References (46)

1. ALTORKI, N., SCHWARTZ, G.K., BLUNDELL, M., DAVIS, B.M., KELSEN, D.P., and ALBINO, A.P. (1993). Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential. Cancer 72, 649-657.
2. ARUGA, A., YAMAUCHI, K., TAKASAKI, K., FURUKAWA, T., and HANYU, F. (1991). Induction of autologous tumor-specific cytotoxic T cells in patients with liver cancer. Characterizations and clinical utilization. Int. J. Cancer 49, 19-24.
3. BAKKER, A.B.H., SCHREURS, M.W.J., DE BOER, A.J., KAWAKAMI, Y., ROSENBERG, S.A., ADEMA, G.J., and FIGDOR, C.G. (1994). Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179, 1005-1009.
4. BLANKENSTEIN, T., QIN, Z.H., ÜBERLA, K., MÜLLER, W., ROSEN, H., VOLK, H.D., and DIAMANTSTEIN, T. (1991). Tumor suppression after tumor cell-targeted tumor necrosis factor α gene transfer. J. Exp. Med. 173, 1047-1052.
5. DANOS, O., and MULLIGAN, R.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85, 6460-6464.
6. DEGIOVANNI, G., LAHAYE, T., HÈRIN, M., HAINAUT, P., and BOON, T. (1988). Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones. Eur. J. Immunol. 18, 671-676.
7. DE PLAEN, E., ARDEN, K., TRAVERSARI, C., GAFORIO, J.J., SZIKORA, J.-P., DE SMET, C., BRASSEUR, F., VAN DER BRUGGEN, P., LETHÈ, B., LURQUIN, C., BRASSEUR, R., CHOMEZ, P., DE BACKER, O., CAVENEE, W., and BOON, T. (1994). Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40, 360-369.
8. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543.
9. FUJII, S., LIU, Y., NEDA, H., ITOH, Y., KOSHITA, Y., TAKAHASHI, M., WATANABE, N., KOUGO, Y., and NIITSU, Y. (1994). Augmented systemic immunity in mice implanted with TNF-α gene transduced Meth-A cells. Jpn. J. Cancer Res. 85, 315-324.
10. ITOH, Y., KOHGO, Y., WATANABE, N., KANISAWA, Y., SAKAMAKI, S., TAKAHASHI, M., HIRAYAMA, Y., ONO, H., HIMENO, T., and NIITSU, Y. (1991). Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells. Jpn. J. Cancer Res. 82, 1203-1206.
11. ITOH, Y., KOSHITA, Y., TAKAHASHI, M., WATANABE, N., KOHGO, Y., and NIITSU, Y. (1995). Characterization of tumor-necrosis-factor-gene-transduced tumor-infiltrating lymphocytes from ascitic fluid of cancer patients: analysis of cytolytic activity, growth rate, adhesion molecule expression and cytokine production. Cancer Immunol. Immunother. 40, 95-102.
12. JAFFEE, E.M., DRANOFF, G., COHEN, L.K., HAUDA, K.M., CLIFT, S., MARSHALL, F.F., MULLIGAN, R.C., and PARDOLL, D.M. (1993). High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res. 53, 2221-2226.
13. KAWAWKAMI, Y., ELIYASU, S., SAKAGUTI, K., ROBBINS, P.F., RIVOLTINI, L., YANNELLI, J.R., APPELLA, E., and ROSENBERG, S.A. (1994). Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180, 347-352.
14. KIM, H.J., HEO, D.S., SUH, C.I., KIM, H.T., BANG, Y.J., and KIM, N.K. (1995). In vitro generation of immune effector cells from tumor-associated lymphocytes of human gastric cancer. Anticancer Res. 15, 1247-1256.
15. KOSHITA, Y., LU, Y., FUJII, S., NEDA, H., MATUYAMA, T., SATO, Y., ITOH, Y., TAKAHASHI, M., KATO, J., SAKAMAKI, S., WATANABE, N., KOHGO, Y., and NIITSU, Y. (1995). Efficacy of the TNF-α gene-transduced tumor cells in treatment of established in vivo tumor. Int. J. Cancer 63, 130-135.
16. KNUTH, A., WÖLFEL, T., KLEHMANN, E., BOON, T., and MEYER ZUM BÜSCHENFELDE, K-H. (1989). Cytolytic T-cell clones against an autologous human melanoma: Specificity study and definition of three antigens by immunoselection. Proc. Natl. Acad. Sci. USA 86, 2804-2808.
17. MARINCOLA, F.M., ETTINGHAUSEN, S., COHEN, P.A., CHESHIRE, L.B., RESTIFO, N.P., MULÉ, J.J., and ROSENBERG, S.A. (1994). Treatment of established lung metastasis with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-α. J. Immunol. 152, 3501-3513.
18. NUCHTERN, J.G., BONIFACINO, J.S., BIDDISON, W.E., and KLAUSNER, R.D. (1989). Brefeldin A implicates egress from endoplasmic reticulum in classI restricted antigen presentation. Nature 339, 223-226.
19. OKAMOTO, T., WATANABE, N., YAMAUCHI, N., TSUJI, Y., TSUJI, N., ITOH, Y., NEDA, H., and NIITSU, Y. (1992). Endogeneous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res. 52, 5278-5281.
20. ØSTENSEN, M.E., THIELE, D.L., and LIPSKY, P.E. (1987). Tumor necrosis factor-α enhances cytolytic activity of human natural killer cells. J. Immunol. 138, 4185-4191.
21. OWEN-SCHAUB, L.B., GUTTERMAN, J.U., and GRIMM, E.A. (1988). Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor α and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Cancer Res. 48, 788-792.
22. PENNICA, D., NEDWIN, G.E., HAYFLICK, J.S., SEEBURG, P.H., DERYNCK, R., PALLADINO, M.A., KOHR, W.J., AGGARWAL, B.B., and GOEDDEL, D.V. (1984). Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312, 724-729.
23. PEOPLES, G.E., GOEDEGEBUURE, P.S., SMITH, R., LINEHAN, D.C., YOSHINO, I., and EBERLEIN, T.J. (1995). Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc. Natl. Acad. Sci. USA 92, 432-436.
24. PFIZENMAIER, K., SCHEURICH, P., SCHLÜTER, C., and KRÖNKE, M. (1987). Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. J. Immunol. 138, 975-980.
25. PLAETINCK, G., DECLERCQ, W., TAVERNIER, J., NABHOLZ, M., and FIERS, W. (1987). Recombinant tumor necrosis factor can induce interleukin 2 receptor expression and cytolytic activity in a rat X mouse T cell hybrid. Eur. J. Immunol. 17, 1835-1838.
26. PLATSOUCAS, C.D., and GOOD, R.A. (1981). Inhibition of specific cell mediated cytotoxicity by monoclonal antibodies to human T cell antigens. Proc. Natl. Acad. Sci. USA 78, 4500-4504.
27. RANGES, G.E., FIGARI, I.S., ESPEVIK, T., and PALLADINO, M.A., JR. (1987). Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α. J. Exp. Med. 166, 991-998.
28. RANSOM, J.H., PELLE, B.A., HUBERS, H., KEYNTON, L.M., HANNA, JR., M.G., and POMATO, N. (1993). Identification of colon-tumor-associated antigens by T-cell lines derived from tumor-infiltrating lymphocytes and peripheral-blood lymphocytes from patients immunized with an autologous tumor-cells/bacillus Calmette-Guérin vaccine. Int. J. Cancer 54, 734-740.
29. ROTHLEIN, R., CZAJKOWSKI, M., O'NEILL, M.M., MARLIN, S.D., MAINOLFI, E., and MERLUZZI, V.J. (1988). Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J. Immunol. 141, 1665-1669.
30. RUBIN, J., CHARBONEAU, J.W., READING, C., and KOVACH, J.S. (1994). Clinical protocol: Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer. Hum. Gene. Ther. 5, 1385-1399.
31. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
32. SANDA, M.G., AYYAGARI, S.R., JAFFEE, E.M., EPSTEIN, J.I., CLIFT, S.L., COHEN, L.K., DRANOFF, G., PARDOLL, D.M., MULLIGAN, R.C., and SIMONS, J.W. (1994). Demonstration of a rational strategy for human prostate cancer gene therapy. J. Urol. 151, 622-628.
33. SHIMIZU, Y., IWATSUKI, S., HERBERMAN, R.B., and WHITESIDE, T.L. (1991a). Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors. Cancer Immunol. Immunother. 32, 280-288.
34. SHIMIZU, Y., WEIDMANN, E., IWATUKI, S., HERBERMAN, R.B., and WHITESIDE, T.L. (1991b). Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Res. 51, 6153-6162.
35. SOBOL, R.E., ROYSTON, I., FAKHRAI, H., SHAWLER, D.L., CARSON, C., DORIGO, O., GJERSET, R., GOLD, D.P., KOZIOL, J., MERCOLA, D., VAN BEVEREN, C., and WILSON, D. (1995). Clinical protocol: Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secreted interleukin-2: A phase I study. Hum. Gene. Ther. 6, 195-204.
36. TEPPER, R.I., and MULÉ, J.J. (1994). Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther. 5, 153-164.
37. TORRE-AMIONE, G., BEAUCHAMP, R.D., KOEPPEN, H., PARK, B.H., SCHREIBER, H., MOSES, H.L., and ROWLEY, D.A. (1990). A highly immunogenic tumor transfected with a murine transforming growth factor type β1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA 87, 1486-1490.
38. USUDA, S., YOSHIZAWA, K., YABU, K., and KIYOSAWA, K. (1993). Immunological responses against an augologous human hepatocellular carcinoma cell line. J. Gastroenterol. Hepatol. 8, 517-523.
39. UEDA, D., SATO, N., MATSUURA, A., SASAKI, A., TAKAHASHI, S., IKEDA, H., WADA, Y., and KIKUCHI, K. (1995). T-cell receptor gene structures of HLA-A26-restricted cytotoxic T lymphocyte lines against human autologous pancreatic adenocarcinoma. Jpn. J. Cancer Res. 86, 691-697.
40. WADA, Y., IKEDA, H., UEDA, D., OHTA, M., TAKAHASHI, S., HIRATA, K., SATO, N., and KIKUCHI, K. (1993). Brefeldin A blocks the cytotoxicity of T cell receptor α/β and γ/δ cytotoxic T lymphocyte clones reacting against human autologous cancer cells. Jpn. J. Cancer Res. 84, 906-913.
41. WAKIMOTO, H., ABE, J., TSUNODA, R., AOYAGI, M., HIRAKAWA, K., and HAMADA, H. (1996). Intensified antitumor immunity by cancer vaccine producing CM-CSF plus IL-4. Cancer Res. (in press).
42. WATANABE, N., NIITSU, Y., NEDA, H., SONE, H., YAMAUCHI, N., UMETSU, T., and URUSHIZAKI, I. (1985). Antitumor effect of tumor necrosis factor against various primarily cultured human cancer cells. Jpn. J. Cancer Res. 76, 1115-1119.
43. WÖLFEL, T., HERR, W., COULIE, P., SCHMITT, U., MEYER ZUM BÜSCHENFELDE, K-H., and KNUTH, A. (1993). Lysis of human pancreatic adenocarcinoma cells by autologous HLA-classI-restricted cytolytic T-lymphocyte (CTL) clones. Int. J. Cancer 54, 636-644.
44. WÖLFEL, T., VAN PEL, A., BRICHARD, V., SCHNEIDER, J., SELIGER, B., MEYER ZUM BÜSCHENFELDE, K-H., and BOON, T. (1994). Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24, 759-764.
45. YASOSHIMA, T., SATO, N., HIRATA, K., and KIKUCHI, K. (1995). The mechanism of human autologous gastric signet ring cell tumor rejection by cytotoxic T lymphocytes in the possible context of HLA-A31 molecule. Cancer 75, 1484-1489.
46. ZIER, K.S., and GANSBACHER, B. (1995). The impact of gene therapy on T cell function in cancer. Hum. Gene. Ther. 6, 1259-1264.